サマリー

医薬品開発業務受託機関（CRO）の世界市場 2024-2028
医薬品開発業務受託機関（CRO）市場は、2023年から2028年にかけて633億5000万米ドルの成長が予測され、予測期間中のCAGRは12.61%で加速すると予測されています。この調査レポートは、医薬品開発業務受託機関（CRO）市場の全体的な分析、市場規模、予測、動向、成長促進要因、課題、さらに約25のベンダーを網羅したベンダー分析を掲載しています。
本レポートでは、現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、バイオ医薬品産業の成長、慢性疾患の有病率の増加、ベンダーによるM&A活動の増加によって牽引されています。
テクナビオのCRO（医薬品開発業務受託機関）市場は以下のようにセグメント化されています：
用途別
- 臨床研究
- 開発初期段階
- ラボ
- 薬事コンサルティング
エンドユーザー別
- 製薬・バイオ医薬品企業
- 医療機器メーカー
- 学術機関
地域別
- 北米
- ヨーロッパ
- アジア
- その他の地域（ROW）
本調査では、臨床試験件数の増加が、今後数年間の医薬品開発業務受託機関（CRO）市場の成長を促進する主な要因の1つであるとしている。また、ワクチン製造の増加、CROサービスの利用によるアウトソーシングとコスト削減の拡大は、市場の大きな需要につながる。
この調査レポートは、医薬品開発業務受託機関（CRO）市場について調査・分析した結果をまとめたものです：
- 医薬品開発業務受託機関（CRO）市場のサイジング
- 医薬品開発業務受託機関（CRO）市場予測
- 開発業務受託機関（CRO）市場の産業分析
Ltd.、ICON plc、IQVIA Holdings Inc.、Konecranes、Laboratory Corp.Ltd.、Medpace Holdings Inc.、Novotech Health Holdings、Parexel International Corp.、Pharmaron Beijing Co.Ltd.、Syneos Health Inc.、Thermo Fisher Scientific Inc.、WuXi AppTec Co.Ltd.、Pharmaron Beijing Co.また、医薬品開発業務受託機関（CRO）市場分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものである。
本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/contract-research-organization-cro-market-industry-analysis をご覧ください。
当出版社では、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、要約する方法で市場の詳細な姿を提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
o Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2023
o 3.4 Market outlook: Forecast for 2023-2028
o Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
o Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• 4 Historic Market Size
o 4.1 Global contract research organization (CRO) market 2018 - 2022
o Exhibit 18: Historic Market Size - Data Table on global contract research organization (cro) market 2018 - 2022 ($ billion)
o 4.2 Application Segment Analysis 2018 - 2022
o Exhibit 19: Historic Market Size - Application Segment 2018 - 2022 ($ billion)
o 4.3 End-user Segment Analysis 2018 - 2022
o Exhibit 20: Historic Market Size - End-user Segment 2018 - 2022 ($ billion)
o 4.4 Geography Segment Analysis 2018 - 2022
o Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
o 4.5 Country Segment Analysis 2018 - 2022
o Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
• 6 Market Segmentation by Application
o 6.1 Market segments
o Exhibit 30: Chart on Application - Market share 2023-2028 (%)
o Exhibit 31: Data Table on Application - Market share 2023-2028 (%)
o 6.2 Comparison by Application
o Exhibit 32: Chart on Comparison by Application
o Exhibit 33: Data Table on Comparison by Application
o 6.3 Clinical research - Market size and forecast 2023-2028
o Exhibit 34: Chart on Clinical research - Market size and forecast 2023-2028 ($ billion)
o Exhibit 35: Data Table on Clinical research - Market size and forecast 2023-2028 ($ billion)
o Exhibit 36: Chart on Clinical research - Year-over-year growth 2023-2028 (%)
o Exhibit 37: Data Table on Clinical research - Year-over-year growth 2023-2028 (%)
o 6.4 Early phase development - Market size and forecast 2023-2028
o Exhibit 38: Chart on Early phase development - Market size and forecast 2023-2028 ($ billion)
o Exhibit 39: Data Table on Early phase development - Market size and forecast 2023-2028 ($ billion)
o Exhibit 40: Chart on Early phase development - Year-over-year growth 2023-2028 (%)
o Exhibit 41: Data Table on Early phase development - Year-over-year growth 2023-2028 (%)
o 6.5 Laboratory - Market size and forecast 2023-2028
o Exhibit 42: Chart on Laboratory - Market size and forecast 2023-2028 ($ billion)
o Exhibit 43: Data Table on Laboratory - Market size and forecast 2023-2028 ($ billion)
o Exhibit 44: Chart on Laboratory - Year-over-year growth 2023-2028 (%)
o Exhibit 45: Data Table on Laboratory - Year-over-year growth 2023-2028 (%)
o 6.6 Regulatory consulting - Market size and forecast 2023-2028
o Exhibit 46: Chart on Regulatory consulting - Market size and forecast 2023-2028 ($ billion)
o Exhibit 47: Data Table on Regulatory consulting - Market size and forecast 2023-2028 ($ billion)
o Exhibit 48: Chart on Regulatory consulting - Year-over-year growth 2023-2028 (%)
o Exhibit 49: Data Table on Regulatory consulting - Year-over-year growth 2023-2028 (%)
o 6.7 Market opportunity by Application
o Exhibit 50: Market opportunity by Application ($ billion)
o Exhibit 51: Data Table on Market opportunity by Application ($ billion)
• 7 Market Segmentation by End-user
o 7.1 Market segments
o Exhibit 52: Chart on End-user - Market share 2023-2028 (%)
o Exhibit 53: Data Table on End-user - Market share 2023-2028 (%)
o 7.2 Comparison by End-user
o Exhibit 54: Chart on Comparison by End-user
o Exhibit 55: Data Table on Comparison by End-user
o 7.3 Pharmaceutical and biopharmaceutical companies - Market size and forecast 2023-2028
o Exhibit 56: Chart on Pharmaceutical and biopharmaceutical companies - Market size and forecast 2023-2028 ($ billion)
o Exhibit 57: Data Table on Pharmaceutical and biopharmaceutical companies - Market size and forecast 2023-2028 ($ billion)
o Exhibit 58: Chart on Pharmaceutical and biopharmaceutical companies - Year-over-year growth 2023-2028 (%)
o Exhibit 59: Data Table on Pharmaceutical and biopharmaceutical companies - Year-over-year growth 2023-2028 (%)
o 7.4 Medical device companies - Market size and forecast 2023-2028
o Exhibit 60: Chart on Medical device companies - Market size and forecast 2023-2028 ($ billion)
o Exhibit 61: Data Table on Medical device companies - Market size and forecast 2023-2028 ($ billion)
o Exhibit 62: Chart on Medical device companies - Year-over-year growth 2023-2028 (%)
o Exhibit 63: Data Table on Medical device companies - Year-over-year growth 2023-2028 (%)
o 7.5 Academic institutes - Market size and forecast 2023-2028
o Exhibit 64: Chart on Academic institutes - Market size and forecast 2023-2028 ($ billion)
o Exhibit 65: Data Table on Academic institutes - Market size and forecast 2023-2028 ($ billion)
o Exhibit 66: Chart on Academic institutes - Year-over-year growth 2023-2028 (%)
o Exhibit 67: Data Table on Academic institutes - Year-over-year growth 2023-2028 (%)
o 7.6 Market opportunity by End-user
o Exhibit 68: Market opportunity by End-user ($ billion)
o Exhibit 69: Data Table on Market opportunity by End-user ($ billion)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 71: Chart on Market share By Geographical Landscape 2023-2028 (%)
o Exhibit 72: Data Table on Market share By Geographical Landscape 2023-2028 (%)
o 9.2 Geographic comparison
o Exhibit 73: Chart on Geographic comparison
o Exhibit 74: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2023-2028
o Exhibit 75: Chart on North America - Market size and forecast 2023-2028 ($ billion)
o Exhibit 76: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
o Exhibit 77: Chart on North America - Year-over-year growth 2023-2028 (%)
o Exhibit 78: Data Table on North America - Year-over-year growth 2023-2028 (%)
o 9.4 Europe - Market size and forecast 2023-2028
o Exhibit 79: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
o Exhibit 80: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
o Exhibit 81: Chart on Europe - Year-over-year growth 2023-2028 (%)
o Exhibit 82: Data Table on Europe - Year-over-year growth 2023-2028 (%)
o 9.5 Asia - Market size and forecast 2023-2028
o Exhibit 83: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
o Exhibit 84: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
o Exhibit 85: Chart on Asia - Year-over-year growth 2023-2028 (%)
o Exhibit 86: Data Table on Asia - Year-over-year growth 2023-2028 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
o Exhibit 87: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
o Exhibit 88: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
o Exhibit 89: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
o Exhibit 90: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
o 9.7 US - Market size and forecast 2023-2028
o Exhibit 91: Chart on US - Market size and forecast 2023-2028 ($ billion)
o Exhibit 92: Data Table on US - Market size and forecast 2023-2028 ($ billion)
o Exhibit 93: Chart on US - Year-over-year growth 2023-2028 (%)
o Exhibit 94: Data Table on US - Year-over-year growth 2023-2028 (%)
o 9.8 China - Market size and forecast 2023-2028
o Exhibit 95: Chart on China - Market size and forecast 2023-2028 ($ billion)
o Exhibit 96: Data Table on China - Market size and forecast 2023-2028 ($ billion)
o Exhibit 97: Chart on China - Year-over-year growth 2023-2028 (%)
o Exhibit 98: Data Table on China - Year-over-year growth 2023-2028 (%)
o 9.9 Germany - Market size and forecast 2023-2028
o Exhibit 99: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
o Exhibit 100: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
o Exhibit 101: Chart on Germany - Year-over-year growth 2023-2028 (%)
o Exhibit 102: Data Table on Germany - Year-over-year growth 2023-2028 (%)
o 9.10 Canada - Market size and forecast 2023-2028
o Exhibit 103: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
o Exhibit 104: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
o Exhibit 105: Chart on Canada - Year-over-year growth 2023-2028 (%)
o Exhibit 106: Data Table on Canada - Year-over-year growth 2023-2028 (%)
o 9.11 UK - Market size and forecast 2023-2028
o Exhibit 107: Chart on UK - Market size and forecast 2023-2028 ($ billion)
o Exhibit 108: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
o Exhibit 109: Chart on UK - Year-over-year growth 2023-2028 (%)
o Exhibit 110: Data Table on UK - Year-over-year growth 2023-2028 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 111: Market opportunity By Geographical Landscape ($ billion)
o Exhibit 112: Data Tables on Market opportunity By Geographical Landscape ($ billion)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 113: Impact of drivers and challenges in 2023 and 2028
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 114: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 115: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 116: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 117: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 118: Matrix on vendor position and classification
o 12.3 BioAgile Therapeutics Pvt. Ltd
o Exhibit 119: BioAgile Therapeutics Pvt. Ltd - Overview
o Exhibit 120: BioAgile Therapeutics Pvt. Ltd - Product / Service
o Exhibit 121: BioAgile Therapeutics Pvt. Ltd - Key offerings
o 12.4 Charles River Laboratories International Inc.
o Exhibit 122: Charles River Laboratories International Inc. - Overview
o Exhibit 123: Charles River Laboratories International Inc. - Business segments
o Exhibit 124: Charles River Laboratories International Inc. - Key news
o Exhibit 125: Charles River Laboratories International Inc. - Key offerings
o Exhibit 126: Charles River Laboratories International Inc. - Segment focus
o 12.5 CTI Clinical Trial and Consulting Inc.
o Exhibit 127: CTI Clinical Trial and Consulting Inc. - Overview
o Exhibit 128: CTI Clinical Trial and Consulting Inc. - Product / Service
o Exhibit 129: CTI Clinical Trial and Consulting Inc. - Key offerings
o 12.6 Ergomed Plc
o Exhibit 130: Ergomed Plc - Overview
o Exhibit 131: Ergomed Plc - Business segments
o Exhibit 132: Ergomed Plc - Key news
o Exhibit 133: Ergomed Plc - Key offerings
o Exhibit 134: Ergomed Plc - Segment focus
o 12.7 Eurofins Scientific SE
o Exhibit 135: Eurofins Scientific SE - Overview
o Exhibit 136: Eurofins Scientific SE - Business segments
o Exhibit 137: Eurofins Scientific SE - Key news
o Exhibit 138: Eurofins Scientific SE - Key offerings
o Exhibit 139: Eurofins Scientific SE - Segment focus
o 12.8 ICON plc
o Exhibit 140: ICON plc - Overview
o Exhibit 141: ICON plc - Product / Service
o Exhibit 142: ICON plc - Key offerings
o 12.9 IQVIA Holdings Inc.
o Exhibit 143: IQVIA Holdings Inc. - Overview
o Exhibit 144: IQVIA Holdings Inc. - Business segments
o Exhibit 145: IQVIA Holdings Inc. - Key news
o Exhibit 146: IQVIA Holdings Inc. - Key offerings
o Exhibit 147: IQVIA Holdings Inc. - Segment focus
o 12.10 Konecranes
o Exhibit 148: Konecranes - Overview
o Exhibit 149: Konecranes - Business segments
o Exhibit 150: Konecranes - Key offerings
o Exhibit 151: Konecranes - Segment focus
o 12.11 Laboratory Corp. of America Holdings
o Exhibit 152: Laboratory Corp. of America Holdings - Overview
o Exhibit 153: Laboratory Corp. of America Holdings - Business segments
o Exhibit 154: Laboratory Corp. of America Holdings - Key news
o Exhibit 155: Laboratory Corp. of America Holdings - Key offerings
o Exhibit 156: Laboratory Corp. of America Holdings - Segment focus
o 12.12 Medpace Holdings Inc.
o Exhibit 157: Medpace Holdings Inc. - Overview
o Exhibit 158: Medpace Holdings Inc. - Product / Service
o Exhibit 159: Medpace Holdings Inc. - Key offerings
o 12.13 Novotech Health Holdings
o Exhibit 160: Novotech Health Holdings - Overview
o Exhibit 161: Novotech Health Holdings - Product / Service
o Exhibit 162: Novotech Health Holdings - Key offerings
o 12.14 Parexel International Corp.
o Exhibit 163: Parexel International Corp. - Overview
o Exhibit 164: Parexel International Corp. - Product / Service
o Exhibit 165: Parexel International Corp. - Key news
o Exhibit 166: Parexel International Corp. - Key offerings
o 12.15 Syneos Health Inc.
o Exhibit 167: Syneos Health Inc. - Overview
o Exhibit 168: Syneos Health Inc. - Business segments
o Exhibit 169: Syneos Health Inc. - Key offerings
o Exhibit 170: Syneos Health Inc. - Segment focus
o 12.16 Thermo Fisher Scientific Inc.
o Exhibit 171: Thermo Fisher Scientific Inc. - Overview
o Exhibit 172: Thermo Fisher Scientific Inc. - Business segments
o Exhibit 173: Thermo Fisher Scientific Inc. - Key news
o Exhibit 174: Thermo Fisher Scientific Inc. - Key offerings
o Exhibit 175: Thermo Fisher Scientific Inc. - Segment focus
o 12.17 WuXi AppTec Co. Ltd.
o Exhibit 176: WuXi AppTec Co. Ltd. - Overview
o Exhibit 177: WuXi AppTec Co. Ltd. - Business segments
o Exhibit 178: WuXi AppTec Co. Ltd. - Key offerings
o Exhibit 179: WuXi AppTec Co. Ltd. - Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 180: Inclusions checklist
o Exhibit 181: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 182: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 183: Research methodology
o Exhibit 184: Validation techniques employed for market sizing
o Exhibit 185: Information sources
o 13.5 List of abbreviations
o Exhibit 186: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Application
Exhibits6: Executive Summary - Chart on Market Segmentation by End-user
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size - Data Table on global contract research organization (cro) market 2018 - 2022 ($ billion)
Exhibits19: Historic Market Size - Application Segment 2018 - 2022 ($ billion)
Exhibits20: Historic Market Size - End-user Segment 2018 - 2022 ($ billion)
Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
Exhibits23: Five forces analysis - Comparison between 2023 and 2028
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition - Five forces 2023 and 2028
Exhibits30: Chart on Application - Market share 2023-2028 (%)
Exhibits31: Data Table on Application - Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Application
Exhibits33: Data Table on Comparison by Application
Exhibits34: Chart on Clinical research - Market size and forecast 2023-2028 ($ billion)
Exhibits35: Data Table on Clinical research - Market size and forecast 2023-2028 ($ billion)
Exhibits36: Chart on Clinical research - Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Clinical research - Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Early phase development - Market size and forecast 2023-2028 ($ billion)
Exhibits39: Data Table on Early phase development - Market size and forecast 2023-2028 ($ billion)
Exhibits40: Chart on Early phase development - Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Early phase development - Year-over-year growth 2023-2028 (%)
Exhibits42: Chart on Laboratory - Market size and forecast 2023-2028 ($ billion)
Exhibits43: Data Table on Laboratory - Market size and forecast 2023-2028 ($ billion)
Exhibits44: Chart on Laboratory - Year-over-year growth 2023-2028 (%)
Exhibits45: Data Table on Laboratory - Year-over-year growth 2023-2028 (%)
Exhibits46: Chart on Regulatory consulting - Market size and forecast 2023-2028 ($ billion)
Exhibits47: Data Table on Regulatory consulting - Market size and forecast 2023-2028 ($ billion)
Exhibits48: Chart on Regulatory consulting - Year-over-year growth 2023-2028 (%)
Exhibits49: Data Table on Regulatory consulting - Year-over-year growth 2023-2028 (%)
Exhibits50: Market opportunity by Application ($ billion)
Exhibits51: Data Table on Market opportunity by Application ($ billion)
Exhibits52: Chart on End-user - Market share 2023-2028 (%)
Exhibits53: Data Table on End-user - Market share 2023-2028 (%)
Exhibits54: Chart on Comparison by End-user
Exhibits55: Data Table on Comparison by End-user
Exhibits56: Chart on Pharmaceutical and biopharmaceutical companies - Market size and forecast 2023-2028 ($ billion)
Exhibits57: Data Table on Pharmaceutical and biopharmaceutical companies - Market size and forecast 2023-2028 ($ billion)
Exhibits58: Chart on Pharmaceutical and biopharmaceutical companies - Year-over-year growth 2023-2028 (%)
Exhibits59: Data Table on Pharmaceutical and biopharmaceutical companies - Year-over-year growth 2023-2028 (%)
Exhibits60: Chart on Medical device companies - Market size and forecast 2023-2028 ($ billion)
Exhibits61: Data Table on Medical device companies - Market size and forecast 2023-2028 ($ billion)
Exhibits62: Chart on Medical device companies - Year-over-year growth 2023-2028 (%)
Exhibits63: Data Table on Medical device companies - Year-over-year growth 2023-2028 (%)
Exhibits64: Chart on Academic institutes - Market size and forecast 2023-2028 ($ billion)
Exhibits65: Data Table on Academic institutes - Market size and forecast 2023-2028 ($ billion)
Exhibits66: Chart on Academic institutes - Year-over-year growth 2023-2028 (%)
Exhibits67: Data Table on Academic institutes - Year-over-year growth 2023-2028 (%)
Exhibits68: Market opportunity by End-user ($ billion)
Exhibits69: Data Table on Market opportunity by End-user ($ billion)
Exhibits70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits71: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits72: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits73: Chart on Geographic comparison
Exhibits74: Data Table on Geographic comparison
Exhibits75: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits76: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits77: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits78: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits79: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits80: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits81: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits82: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits83: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits84: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits85: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits86: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits87: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits88: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits89: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits90: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits91: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibits92: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibits93: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits94: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits95: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibits96: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibits97: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits98: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits99: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits100: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits101: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits102: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits103: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibits104: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibits105: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits106: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits107: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits108: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits109: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits110: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits111: Market opportunity By Geographical Landscape ($ billion)
Exhibits112: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits113: Impact of drivers and challenges in 2023 and 2028
Exhibits114: Overview on Criticality of inputs and Factors of differentiation
Exhibits115: Overview on factors of disruption
Exhibits116: Impact of key risks on business
Exhibits117: Vendors covered
Exhibits118: Matrix on vendor position and classification
Exhibits119: BioAgile Therapeutics Pvt. Ltd - Overview
Exhibits120: BioAgile Therapeutics Pvt. Ltd - Product / Service
Exhibits121: BioAgile Therapeutics Pvt. Ltd - Key offerings
Exhibits122: Charles River Laboratories International Inc. - Overview
Exhibits123: Charles River Laboratories International Inc. - Business segments
Exhibits124: Charles River Laboratories International Inc. - Key news
Exhibits125: Charles River Laboratories International Inc. - Key offerings
Exhibits126: Charles River Laboratories International Inc. - Segment focus
Exhibits127: CTI Clinical Trial and Consulting Inc. - Overview
Exhibits128: CTI Clinical Trial and Consulting Inc. - Product / Service
Exhibits129: CTI Clinical Trial and Consulting Inc. - Key offerings
Exhibits130: Ergomed Plc - Overview
Exhibits131: Ergomed Plc - Business segments
Exhibits132: Ergomed Plc - Key news
Exhibits133: Ergomed Plc - Key offerings
Exhibits134: Ergomed Plc - Segment focus
Exhibits135: Eurofins Scientific SE - Overview
Exhibits136: Eurofins Scientific SE - Business segments
Exhibits137: Eurofins Scientific SE - Key news
Exhibits138: Eurofins Scientific SE - Key offerings
Exhibits139: Eurofins Scientific SE - Segment focus
Exhibits140: ICON plc - Overview
Exhibits141: ICON plc - Product / Service
Exhibits142: ICON plc - Key offerings
Exhibits143: IQVIA Holdings Inc. - Overview
Exhibits144: IQVIA Holdings Inc. - Business segments
Exhibits145: IQVIA Holdings Inc. - Key news
Exhibits146: IQVIA Holdings Inc. - Key offerings
Exhibits147: IQVIA Holdings Inc. - Segment focus
Exhibits148: Konecranes - Overview
Exhibits149: Konecranes - Business segments
Exhibits150: Konecranes - Key offerings
Exhibits151: Konecranes - Segment focus
Exhibits152: Laboratory Corp. of America Holdings - Overview
Exhibits153: Laboratory Corp. of America Holdings - Business segments
Exhibits154: Laboratory Corp. of America Holdings - Key news
Exhibits155: Laboratory Corp. of America Holdings - Key offerings
Exhibits156: Laboratory Corp. of America Holdings - Segment focus
Exhibits157: Medpace Holdings Inc. - Overview
Exhibits158: Medpace Holdings Inc. - Product / Service
Exhibits159: Medpace Holdings Inc. - Key offerings
Exhibits160: Novotech Health Holdings - Overview
Exhibits161: Novotech Health Holdings - Product / Service
Exhibits162: Novotech Health Holdings - Key offerings
Exhibits163: Parexel International Corp. - Overview
Exhibits164: Parexel International Corp. - Product / Service
Exhibits165: Parexel International Corp. - Key news
Exhibits166: Parexel International Corp. - Key offerings
Exhibits167: Syneos Health Inc. - Overview
Exhibits168: Syneos Health Inc. - Business segments
Exhibits169: Syneos Health Inc. - Key offerings
Exhibits170: Syneos Health Inc. - Segment focus
Exhibits171: Thermo Fisher Scientific Inc. - Overview
Exhibits172: Thermo Fisher Scientific Inc. - Business segments
Exhibits173: Thermo Fisher Scientific Inc. - Key news
Exhibits174: Thermo Fisher Scientific Inc. - Key offerings
Exhibits175: Thermo Fisher Scientific Inc. - Segment focus
Exhibits176: WuXi AppTec Co. Ltd. - Overview
Exhibits177: WuXi AppTec Co. Ltd. - Business segments
Exhibits178: WuXi AppTec Co. Ltd. - Key offerings
Exhibits179: WuXi AppTec Co. Ltd. - Segment focus
Exhibits180: Inclusions checklist
Exhibits181: Exclusions checklist
Exhibits182: Currency conversion rates for US$
Exhibits183: Research methodology
Exhibits184: Validation techniques employed for market sizing
Exhibits185: Information sources
Exhibits186: List of abbreviations